Condensed Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income / (loss)	$ (45,000)	$ 9,000
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation	25,000	28,000
Loss on disposal of fixed assets	3,000	0
Amortization of debt issuance costs	42,000	74,000
Provision for bad debts	(2,000)	(6,000)
Provision for slow moving and obsolete inventory	21,000	0
Share-based payment expense	11,000	8,000
Changes in:
Accounts receivable	168,000	(28,000)
Inventory	(111,000)	105,000
Prepaid expenses and other current assets	32,000	(2,000)
Accounts payable	13,000	36,000
Accrued expenses and other current liabilities	(18,000)	(60,000)
Wages payable	38,000	22,000
Other liabilities	0	1,000
Net cash provided by operating activities	177,000	187,000
Cash flows from investing activities:
Patent application costs	(2,000)	(1,000)
Net cash used in investing activities	(2,000)	(1,000)
Cash flows from financing activities:
Proceeds (payments) on debt financing	(1,071,000)	(112,000)
Proceeds from refinance	1,200,000	0
Deferred finance costs	(111,000)	0
Proceeds from lines of credit	1,316,000	1,883,000
Payments on lines of credit	(1,374,000)	(2,082,000)
Net cash (used in) financing activities	(40,000)	(311,000)
Net Increase / (decrease) in cash and cash equivalents	135,000	(125,000)
Cash and cash equivalents - beginning of period	352,000	646,000
Cash and cash equivalents - end of period	487,000	521,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	31,000	46,000
Cash paid during period for taxes	$ 0	$ 1,000